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Thyrotropin-releasing hormone (TRH) reduces an inwardly rectifying K+ current in whole-cell voltage-clamped GH, rat anterior pituitary cells. 
The TRH effect depends on the maintenance of a background level of Ca” in the pipette buffer, and is rapidly minimized by the intracellular dialysis 
produced under whole-cell conditions. Introduction of ADP-NH-P, a non-hydrolizable ATP analog, in the pipettes, nearly abolishes the TRH- 
evoked inhibition. The TRH-induced reduction of the inwardly rectifying current is significantly enhanced by incubation of cells 24 h with cholera 
toxin, but not by inclusion of 1 mM cyclic AMP in the pipettes. Under control whole-cell conditions, the reduction caused by TRH is not reversed 
upon washout of the neuropeptide. However, this effect is readily reversed by addition of purified catalytic subunits of protein phosphatase 2A 
(PP.2AJ but not PP-1, to the buffer used to fill the patch pipettes. Among previous results with PP inhibitors, these data indicate that PP2A is 
involved in the phosphorylation/dephosphorylation mechanism(s) that regulate the delayed TRH effects on GH, cell excitability. 
Thyrotropin-releasing hormone; Inwardly rectifying K+ current; GH, cell; Protein phosphatase; Anterior pituitary 
1. INTRODUCTION 
Thyrotropin-releasing hormone (TRH) produces a 
biphasic effect on clonal rat anterior pituitary GH cells 
excitability, consisting of an initial phase of transient 
hyperplarization followed by a second phase in which 
the membrane conductance is decreased and the rate of 
production and the length of action potentials are in- 
creased [l-5]. It is believed that the increased influx of 
extracellular Ca*’ through voltage-dependent Ca*’ 
channels as a consequence of the elevation in action 
potential frequency is the major cause of a sustained 
plateau of elevated intracellular Ca*+ [5-81, paralleled 
by a sustained increase on prolactin secretion [1,7,9, lo]. 
We have recently shown that TRH-induced reductions 
on the inwardly rectifying K’ current initially described 
by Bauer et al. [l l] play a major role in maintenance of 
resting membrane conductance and regulation of GH3 
cells electrical activity by TRH [4,5,12]. In these earlier 
reports, perforated-patch conditions were used in order 
to correlate voltage-clamp studies on the currents and 
current-clamp analysis of firing frequency, since hormo- 
nal responses and membrane currents which are rapidly 
diminished using the whole-cell configuration, are fully 
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preserved when perforated patches are used [2-$12,131. 
Based on the combined use of okadaic acid and ca- 
lyculin A, two potent and selective inhibitors of protein 
phosphatases, we have shown that the delayed effects of 
TRH on inward rectifying IV currents and hence on cell 
excitability, are regulated by a phosphorylation/ 
dephosphorylation mechanism [4,12]. The concentra- 
tion dependencies of okadaic acid and calyculin A ef- 
fects also suggested that a type 2A protein phosphatase 
was the enzyme specifically involved in reversion of the 
TRH effects [4]. In this report, the whole-cell configura- 
tion of the patch-clamp technique is used in order to 
obtain a more direct control of cell contents. This ap- 
proach and the use of purified catalytic subunits of 
protein phosphatases trengthen the evidence that the 
effects of TRH on inward rectifying K’ currents are 
controlled by phosphorylation. Our results also indicate 
that PP-2A, can specifically and effectively replace the 
intracellular factor(s) lost by dyalisis of the intracellular 
medium and which cause the reversion of the TRH 
effects. Furthermore, the possibility that a cholera 
toxin-sensitive G-protein couples the TRH receptor to 
activation of a protein kinase involved in regulation of 
inward rectifying K’ currents is discussed. 
2. MATERIALS AND METHODS 
TRH, ATP, ADP-NH-P, C.T. and EGTA were purchased from 
Sigma (St. Louis, MO, USA). Maintenance of GH, cells (ATTCC- 
CCL 82.1) has been described previously [3,12]. Whole-cell recordings 
were made at room temperature (2&25”C) in a recording chamber of 
0.2-0.3 ml continuously perfused at 1 ml/min, using a List EPC-7 (List 
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Electronics, Darmstadt, Germany) amplifier. Electrodes of 2-5 MR 
were fabricated from Boralex disposable micropipettes (Rochester 
Scientific, Rochester, NY, USA), and filled with a solution containing 
(in mM): 140 KCl, 2 MgCl,, 0.7 CaCI,, 1.1 EGTA and 10 HEPES 
titrated to pH 7.4 with KOH. The amount of free Ca*’ in this solution 
amounts 20&250 nM [ll]. For experiments in which a Ca*‘-free 
internal solution was used, no CaCl, was added and EGTA was raised 
to 10 mM. Seals were obtained in an extracellular-like solution con- 
taining (in mM): 140 NaCl, 1 KCl, 1 MgCl,, 10 glucose, 10 CaCl, and 
10 HEPES titrated to pH 7.4 with NaOH [12]. Immediately after 
breaking the patch, this solution was changed to high-K’,Ca*‘-free 
medium in order to maximize currents through inwardly rectifying K’ 
channels. This medium contained (in mM): 140 KCI, 4 MgCl,, 10 
EGTA and 10 HEPES titrated to pH 7.4 with KOH. In experiments 
designed to check the effects of PPs, the KC1 concentration was re- 
duced to 115 mM in both internal and external solution to maintain 
osmolarity and symmetrical K+ concentrations. This adjustment was 
performed in order to compenstate the nearly 50 mM glycerol added 
from the PPs stocks. In these cases, extracellular and control pipette 
solutions also received the indicated amounts of glycerol. Cell stimula- 
tion and acquisition of membrane currents under voltage-clamp were 
performed using an Atari computer and commercial software (In- 
strutech Corp., Elmont, NY, USA). Current records were sampled 
every 0.5 ms and digitally filtered at 500 Hz. Data are shown without 
correction for leakage. Uncompensated capacitive transients were 
subtracted using voltage pulses of the same magnitude as those em- 
ployed to generate the currents. These pulses were applied to the cell 
in extracellular-like solution from holding potentials between -90 and 
-60 mV. Series resistance compensation was deliberately not em- 
ployed along the experiments. This allowed us to detect any small 
change in input resistance due to plugging of the pipette which could 
interfere with free difussion through the pipette tip. Such a circum- 
stance, manifested by a change in kinetics and/or magnitude of the 
currents, would be especially relevant given the subtractive procedure 
used to quantify the magnitude of the inward rectifying K+ current (see 
below). On the other hand, it would limit the rapid exchange of pipette 
and/or cellular components along the time span used in the experi- 
ments (see below). In fact, plugging of the pipette tip seemed to be 
propitiated by transient Ca*+ liberations from intracellular stores at 
the beginning of the application of TRH. Therefore, only experiments 
in which amplitude and kinetics of the voltage-dependent K+ current 
tail (see below) remained stable along the whole time course of record- 
ings were used to construct the averaged graphs shown. Data are 
expressed as means f S.E. for the number of cells indicated in paren- 
theses. Preparations of purified PP-2A, and PP-I, were obtained as 
described [14-161 and stored at -20°C in a buffer containing 50% (v/v) 
glycerol, 0.5 mM benzamidine, 0.1 mM EGTA, 0.5 mM dithioerythri- 
to1 and 20 mM Tris- HCl at pH 7.4. These preparations were diluted 
1 :lOO (v/v) in the pipette buffer with KC1 concentration reduced to 115 
mM. Enzymatic activity of the stored preparations was checked with 
a photometric assay with p-nitrophenyl phosphate as substrate as 
described in [14]. One unit of phosphatase was defined as the enzyme 
activity which hydrolyzes 1 pmol ofp-nitrophenyl phosphate in 1 min 
under assay conditions. The specific enzymatic activities of the stocks 
were 0.2 U/mg for PP-1 and 25 U/mg for PP-2A with this substrate. 
Given the relative enzymatic activities uing p-nitrophenyl phosphate 
and phosphorylated myosin light chains as substrates [15], this would 
yield a similar activity for both enzyme preparations with the 
phosphorylated protein. The concentrations of PPs inside the patch 
pipette were 0.53 and 0.28 PM for PP-1, and PP-2A,, respectively. 
Alkaline phosphatase from calf intestine (1 x 10’ U/ml, 3.4 mU/mg) 
was obtained from Boehringer Mannheim (Mannheim, Germany) and 
diluted l:l,OOO (v/v) in the pipette buffer. 
3. RESULTS AND DISCUSSION 
Fig. 1 shows the effect of TRH on inward rectifying 
K’ currents in whole-cell voltage-clamped GH, cells. As 
shown in Figure lA, hyperpolarization of the mem- 
brane from -20 to -100 mV in nearly symmetrical K’ 
solutions elicited inward currents showing an initial 
maximum, followed by a period in which they inactivate 
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Fig. 1. Effect of TRH on inwardly rectifying K’ currents under whole-cell clamp. (A) Representative current traces obtained just before (C) and 
3 min after addition of 100 nM TRH for 40 s (TRH). 500 ms hyperpolarization pulses to - 100 mV from a holding potential of -20 mV were preceded 
by a 100 ms voltage ramp from 0 to -50 mV. Note the inward ‘tail’ current elicited by returning to the holding potential after the hyperpolarization 
pulse (see text for explanations). (B) Time course of the TRH effect under different conditions. Whole-cell patch pipettes contained either a 20& 
250 nM Ca*’ buffer (circles, see Section 2) or a Ca”-free solution with 10 mM EGTA and no calcium added (triangles). Perfusion of the cells with 
100 nM TRH is indicated by an horizontal bar. Entrance of the neuropeptide started either 2 min (open symbols) or 5 min (filled circles) after 
breaking the membrane patch to establish whole-cell conditions. The magnitude of the currents was obtained from the difference between peak 
and steady-state currents during hyperpolarization at -100 mV, and normalized to the averaged value of the data points before addition of TRH. 
Mean and S.E. values are indicated for every experimental time, with the number of averaged cells in parentheses. 
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to reach an steady state. The hyperpolarization pulse 
was preceded by a 100 ms voltage ramp from 0 to -50 
mV, which would yield an estimation of the membrane 
conductance within this voltage range (see [5,12]). Fur- 
thermore, a transient inward tail current is obtained 
after returning to the holding potential, due to activa- 
tion of the transient voltage-dependent K+ current pres- 
ent in these cells. As indicated above (see Section 2) the 
magnitude and kinetics of this current can be used as an 
additional control for specificity of the effects observed 
on the inward rectifier, and also as a detector of input 
resistance changes produced along the time course of 
the experiments. The magnitude of the specific inwardly 
rectifying K’ current can be estimated in the hyperpo- 
larization pulse from the difference between peak and 
steady state currents once complete inactivation is 
achieved. Perfusion of the cells for nearly 1 min with a 
solution containing 100 nM TRH produced a reduction 
of the inwardly rectifying K+ current (Fig. lA,B). The 
magnitude of this reduction was strongly dependent on 
the technical conditions used. Maximal reductions were 
obtained using Ca*+-containing pipettes and TRH addi- 
tions 2-3 min after breaking the membrane patch to 
establish whole-cell conditions (see Section 2). The use 
of Ca*‘-free EGTA-containing electrodes prevented the 
TRH effect. Furthermore, the effect of the neuropeptide 
was minimized when TRH was added 5 min after break- 
ing the membrane patch (Fig. 1B). It is important to 
emphasize that the reductions showed in Fig. 1 B proba- 
bly represent a minimum of which readily happens 
when time in whole-cell is prolonged. Thus, only cells 
showing a detectable reduction of the current have been 
averaged in the graph. This condition is only fulfilled by 
40% of the cells after 5 min of whole-cell, which con- 
trasts with the nearly 70% of cells showing current re- 
ductions bigger than 20% after 2 min of whole-cell. 
Nevertheless, only a delayed 20% reduction is detected 
adding TRH after 5 min of whole-cell, even although 
only the aforementioned 40% population of cells show- 
ing some current reduction is considered. This demon- 
strates that the small response to TRH once 5 min of 
whole-cell had elapsed is not due to choice of TRH- 
unresponsive cells, but is due to the longer maintenance 
of the cells under the intracellular dialysis condition 
inherent to the whole-cell configuration. It is also inter- 
esting to indicate that addition of TRH 3.5 min after 
establishing whole-cell did not significantly alter the 
initial kinetics of TRH-induced current inhibition, but 
reduced its magnitude to a value intermediate between 
those obtained after 2 and 5 min of whole-cell. Further- 
more, the run-down of the hormonal effect was not 
prevented by addition of adenine and guanine nucleo- 
tides to the pipette buffer (data not shown). The techni- 
cal limitations imposed by the need to switch the perfu- 
sion to high-K+ Ca*+-free medium (necessary to meas- 
ure the inward rectifying currents) followed by record- 
ing of several control pulses at a rate (0.03 to 0.1 Hz) 
which does not cause accumulation of current inactiva- 
tion, did not allow us to test hormonal effects at times 
shorter than 2 min. However, the magnitude of the 
current reduction at 2 min of whole-cell parallels that 
obtained under perforated-patch conditions [5,12]. Al- 
together, these data indicate that a period of 2-3 min of 
whole-cell before TRH addition does not greatly impair 
the ability of the neuropeptide to trigger the cascade of 
events leading to reduction of the inward rectifying K+ 
currents. Therefore, this time period was used in the rest 
of the experiments included in this report. 
Although the magnitude of the TRH-evoked reduc- 
tions on the inward rectifying K’ currents is similar 
both under whole-cell and perforated-patch conditions 
(Fig. 1 and [5,12]), it has been previously shown that the 
use of the whole-cell configuration makes such an inhi- 
bition irreversible even several minutes after withdrawal 
of the hormone [l 11. The quite ‘extreme’ conditions (i.e. 
use of high-K+ Ca*+-free xtracellular solutions and ef- 
fective dialysis of intracellular medium) chosen for our 
experiments, made it very difficult to extend the record- 
ings longer than 5-10 min. However, we confirmed pre- 
vious results showing irreversibility of the current inhi- 
bition, even in cells in which washout of TRH could be 
performed by a period of up to 10 min (Fig. 1 B and data 
not shown). These data indicate that although a brief 
dialysis of 2-3 min is not enough to eliminate from the 
cell the component(s) necessary to produce the inhib- 
itory effect, the subsequent recovery of such an effect is 
abolished at the longer whole-cell times at which the 
recovery takes place. 
We have concluded from our previous studies using 
perforated-patch recording and PP inhibitors that a 
phosphorylation is involved in the TRH-induced reduc- 
tion of GH3 cells inward rectifying K+ current causing 
enhanced cell excitability. Furthermore, a dephosphor- 
ylation mechanism is necessary for subsequent recuper- 
ation of the TRH-evoked effects [4,12]. however, a di- 
rect evidence for participation of a protein kinase on the 
TRH effects has been lacking. We took now advantage 
of the fact that the internal medium can be influenced 
by the content of the pipette solution, in order to dem- 
onstrate that ADP-NH-P (a nucleotide which can not 
donate its gamma phosphate in phosphorylation reac- 
tions) can effectively compete with endogenous ATP 
and reduce the inhibition of the inward rectifying K’ 
current by TRH. Introduction of 1 mM of the ATP 
analog in the pipette buffer did not cause any consistent 
effect on the TRH-evoked inhibition of the current (not 
shown). However, the response to TRH was largely 
hampered by raising the ADP-NH-P concentration up 
to 10 mM (Fig. 2B,C). These experiments were per- 
formed filling the pipette tip with nucleotide-free solu- 
tion, followed by back-Blling with nucleotide-contain- 
ing buffer, since no seals were obtained after filling the 
whole content of the electrodes with 10 mM nucleotide- 
containing buffers. In order to exclude the possibility 
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Fig. 2. Effect of adenine nucleotides on inhibition of inward rectifying K’ currents by TRH. (A,B) Representative current traces obtained before 
(C) and 4 mm after addition of 100 nM TRH (TRH). Same voltage protocol as that used in Fig. I. Patch pipettes contamed 10 mM of ATP (A) 
or ADP-NH-P (B) (see text for details). (C) Time course of the TRH effect in the absence of nucleotides (open circles) and in the presence of 10 
mM ATP (triangles) or 10 mM AD&NH-P (filled circles). Control cells as those averaged in Fig. 1 are shown for comparison. 
that the ATP analog prevented the TRH effect by chela- 
tion of the submi~romolar Ca2+ content of the pipette 
buffer, controls were run in the presence of 10 mM 
ATP. As shown in Fig. 2A,C, blockade of the TRH 
effect was specific for ADP-NH-P. These results dem- 
onstrate that the nucleotides are able to diffuse into the 
cell in the time span used in the experiments, even al- 
though the aforementioned b~k-~lling of the patch pi- 
pettes is performed. On the other hand, they also indi- 
cate that at a concentration of 10 mM, the non-hydro- 
lyzable ATP analog is able to effectively compete with 
and/or substitute intracellular ATP, adding further sup- 
CAMP 
6 C.T. 
-10 ’ 1 
0 2 4 6 
t (min) 
Fig. 3. Treatment with CT., but not intracellular CAMP, enhances the TRH-induced inhibition of inward rectifying K+ currents. (A,B) Represen- 
tative current traces obtained before (C) and 4 min after addition of 100 nM TRH (TRH). Data from an untreated cell recorded with a pipette 
containing 1 PM CAMP (A) and a cell treated with 1 &ml C.T. for 3 h (B) are shown. (C) Time course of the TRH effect in cells treated 24 h 
with CT. (filled circles) and in toxin-untreated cells recorded with pipettes containing I mM CAMP (triangles). Untreated cells recorded with 
standard pipette saline (open circles) are also shown for comparison. The triple dots near a symbol denote at least a P < 0.001 level of significance 
respect o control, a double dot P c 0.02 and a single dot P < 0.05. The values of inward rectifying currents normaiiied as in Fig. 1 at each time 
point were compared by a two-tailed Student’s t-test. 
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Fig. 4. Effect of different protein phosphatases on reductions of inward rectifying K’ currents by TRH. (A,B). Representative current races 
obtained before (C), 2 min after addition of 100 nM TRH (TRH) and several minutes after withdrawal of the neuropeptide (washout). Pipettes 
containing either PP.1 (A) or PP-2A (B) purified preparations were used. Washout times were 7 min and 10 min for (A) and (B) respectively. (C) 
Time course of the TRH effect in cells recorded with pipettes containing no protein phosphatase (open circles), PP-1 (triangles) or PP-2A (closed 
circles). Control pipettes and external buffers contained an amount of glycerol equivalent o that added with PPs. Sub~uently, KC1 ~on~ntrations 
were reduced to 115 mM. Note that this maneuver did not modify the TRH-induced inhibition. Significance levels vs. control are expressed by 
dots as in Fig. 3. 
port to the conclusion that a phosphorylation reaction 
is involved in the reduction of the inward rectifying K’ 
current by TRW. 
The identity of the PK involved in the TRH effects 
on the inward rectifier is not known. It has been previ- 
ously suggested that activation of PKC participates in 
the sustained effects of TRH [1,7,9,10] including the 
modulation of the K‘ channel activity, which deter- 
mines the firing rate [1,9,10,17,18]. However, an effect 
of phosphorylation by PKC on a specific K’ conduct- 
ance has not been demonstrated in GH3 cells. On the 
other hand, the reductions on inward rectifying current 
produced by TRH seem to be independent on PKC 
activation [ 11,121. We have previously shown using per- 
forated patches that the hormone-induced inhibition is 
potentiated by treatment of the cells with CT. for 2-4 h 
f5]. The ability of C.T. to ADP-ribosylate the a subunit 
of G, (the GTP-binding protein stimulatory of adenylyl 
cyclase) and to increase intracellular CAMP levels is well 
known [19]. However, neither treatment of the cells with 
inhibitors of PKs A and/or C, nor incubation with per- 
meable CAMP analogs or CAMP phospho- 
diesterase inhibitors were able to modify the TRH-in- 
duced in~bition [5,X?!]. As a more direct way to check 
the possible participation of the cyclic nucleotide (and 
PKA) on TRH effects, we compared the influence of 
pretreatment of the cells with CT. and that of introduc- 
ing CAMP into the cell through the patch pipette. As 
shown in Fig. 3B,C, treatment of GH, cells with C.T. 
for 3 h si~ificantly enhanced the inhibition caused by 
TRH on the inward rectifying current. However, the 
magnitude of the current and the inhibitory effect of 
TRH remained unaltered when CAMP-containing pi- 
pettes were used (Fig. 3A,C). It is important to indicate 
that these experiments were performed tilling the whole 
content of the pipette with CAMP-containing solutions. 
The rapid diffusion of nucleotides demonstrated in the 
experiments hown in Figure 2, excludes that failure to 
detect any effect of CAMP is due to limited entrance of 
the nucleotide into the cell. Among previous results 
[5,11,12], this indicates that activation of PKA by 
cAMP seems not to play a major role on the TRH 
effects. Involvement of a receptor protein kinase such 
as that associated with the /3-adrenergic receptor [20,21] 
is also not probable, since the effect of TRH remains 
unaltered when pipettes containing heparin are used 
(Barros F., unpublished). Clearly, the identity of the PK 
involved on regulation of inward rectifying currents re- 
mains to be established. 
Regardless of the identity of the PK involved on the 
TRH effects, our previous results with perforated 
patches and PP inhibitors suggested that a 
dephospho~lation mechanism is necessary to reverse 
the action of TRW 14,121. This and the irreversibility of 
the TRH effect under whole-cell conditions (this report 
and [ll]) lead to the suggestion that a PP or a factor 
necessary for its activity is lost under whole-cell mode. 
The relative effects of different okadaic acid and caly- 
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culin A concentrations also opened the possibility that 
PP-2A was the enzyme specifically involved in reversion 
of the TRH effect [4]. In order to directly address these 
possibilities, different purified PPs were introduced into 
the cell through the patch pipettes. In this case, the KC1 
concentration of the solutions was adjusted at 115 mM 
to compensate the amount of glycerol (50 mM) added 
with the buffers used to store purified PPs in an active 
form. As shown in Fig. 4A,C the TRH-induced inhibi- 
tion of the inward rectifying K+ current was signifi- 
cantly reversed 2-3 min after retrieval of the hormone 
when PP-2A was included in the buffer used to fill the 
pipette. Although quantitatively not very large, the re- 
versal effect was specific for PP-2A,. Thus, neither PP-1, 
(Fig. 4A,C), alkaline phosphatase from calf intestine, 
nor PP-2& preparations heat inactivated at 100°C for 
10 min (not shown) inside the pipette were able to mod- 
ify the TRH effect at any time. It is also important to 
emphasize that the magnitude of the reversion closely 
resembles that obtained at the same times under perfo- 
rated-patch conditions (e.g. see Fig. 1 in [5]). Although 
the need to perform the TRH additions after a delay no 
longer than 2-3 min (see above) imposes a strong limita- 
tion to these experiments, these results also demonstrate 
that PP-2A, can specifically and effectively replace the 
intracellular factor(s) lost after whole-cell dialysis of the 
intracellular medium. 
The results obtained with ADP-NH-P, a non-hydro- 
lyzable ATP analog, the reversion obtained in the pres- 
ence of PP-2A,, and our previous results with PP inhib- 
itors [4,12], indicate that a phosphorylation is involved 
in the TRH-induced reduction of the inward rectifying 
K’ currents. It is also clear that this effect is modified 
by C.T. in a CAMP-independent way. The modulation 
of the inward rectifying K” current by TRH is mediated 
by a G protein [ll]. In addition to the well known 
coupling to cholera and pertussis toxin insensitive G,, 1 
which activates phospholipase C [22,23], coupling of 
TRH receptors to a C.T.-sensitive GTP-binding protein 
has been reported [24]. Furthermore, although TRH 
acts as a poor activator of adenylate cyclase in GH, 
cells, a direct interaction of the GH3 cell TRH-receptor 
with G,-like protein has also been recently demon- 
strated [253. The CAMP-independent CT.-induced en- 
hancement of the TRH effect could be explained by the 
ADP-ribosylation of a regulatory component (i.e. G, or 
a G,-like protein) of the cascade which couples the TRH 
receptor to inhibition of the inward rectifying K” cur- 
rent. In the absence of hormones, the covalent modifica- 
tion of G, by C.T. can be much more rapid than disso- 
ciation of guanyl nucleotides 126,271. If a similar situa- 
tion takes place in vivo after a relatively short treatment 
of GH, cells with C.T., the acceleration of nucleotide 
exchange in the G-protein by addition of TRH without 
subsequent deactivation of the ADP-~bosyiated 
transducer, could explain the enhanced inhibition of the 
current by the neuropeptide. It could also be expected 
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that extension of the CT. treatment o times at which 
spontaneous or C.T.-induced nucleotide exchange can 
take place would cause a permanent reduction of the 
basal G-protein-regulated current. However, we have 
observed that exposition of GH, cells to C.T. for 15- 
20 h abolishes the TRH-induced inhibition of the in- 
ward rectifier without a substantial reduction of the 
basal current (F. Barros, ~published). As previously 
reported [28], it is possible that such a long treatment 
does not simply maintain an activated population of 
GJX at the plasma membrane, but leads to elimination 
of most of the protein from the cell. Althou~ other 
mechanisms of regulation can also be considered, the 
possibility that TRH modulates GH, cells inward recti- 
fying KC currents, and hence cell excitability, by direct 
coupling of the TRH receptor to a PK via a C.T.-sensi- 
tive G-protein is currently under investigation. 
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